FIELD: medicine.
SUBSTANCE: invention refers to medicine, namely to experimental cardiology and pharmacology, and concerns the endothelial dysfunction correction. That is ensured by a 28-day intragastric administration of a mixture of homeopathic dilutions of vascular endothelial growth factor (VEGF) monoclonal antibodies 2 times a day in a dose of 4.5 mg/kg with underlying intraperitoneal administration of L-NAME 12.5 mg/kg a day into white Wistar rats.
EFFECT: administering the homeopathic dilutions of the VEGF monoclonal antibodies prevents developing the L-NAME induced endothelial dysfunction in the specific experimental environment.
5 cl, 3 ex, 3 tbl
| Title | Year | Author | Number |
|---|---|---|---|
| MEDICATION FOR CORRECTION OF ENDOTHELIAL DYSFUNCTION | 2011 |
|
RU2536228C2 |
| METHOD FOR ENDOTHELIAL DYSFUNCTION CORRECTION | 2011 |
|
RU2542403C2 |
| METHOD FOR CORRECTION OF ENDOTHELIAL DYSFUNCTION | 2011 |
|
RU2527689C2 |
| THERAPEUTIC AGENT FOR ENDOTHELIAL DYSFUNCTION CORRECTION | 2011 |
|
RU2543331C2 |
| THERAPEUTIC AGENT FOR ENDOTHELIAL DYSFUNCTION CORRECTION | 2011 |
|
RU2543332C2 |
| THERAPEUTIC AGENT FOR ENDOTHELIAL DYSFUNCTION CORRECTION | 2011 |
|
RU2500424C2 |
| METHOD FOR CORRECTION OF ENDOTHELIAL DYSFUNCTION | 2011 |
|
RU2526149C2 |
| METHOD FOR CORRECTION OF ENDOTHELIAL DYSFUNCTION BY SOLUTION OF HOMOEOPATHIC DILUTIONS OF INTERLEUKIN-1 ANTIBODIES | 2011 |
|
RU2526150C2 |
| METHOD FOR ENDOTHELIAL DYSFUNCTION CORRECTION BY SOLUTION OF HOMOEOPATHIC DILUTIONS OF INTERLEUKIN-6 ANTIBODIES | 2011 |
|
RU2477530C2 |
| METHOD FOR ENDOTHELIAL DYSFUNCTION CORRECTION BY SOLUTION OF HOMOEOPATHIC DILUTIONS OF HUMAN ENDOTHELIAL NITROGEN OXIDE SYNTHASE ANTIBODIES IN COMPLEX WITH SOLUTION OF HOMOEOPATHIC DILUTIONS OF ANGIOTENSIN II RECEPTOR C-TERMINAL FRAGMENT ANTIBODIES | 2011 |
|
RU2500425C2 |
